APRE

Aprea Therapeutics
$0.63
−$0.01 (−1.11%)Jul 27, 2026
1.1PoorMoatMint rating

MoatMint rates Aprea Therapeutics (APRE) 1.1 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 0.5 out of 10.

Key metrics

The numbers that frame APRE today
Market cap
$7.74M
P/E (TTM)
-0.6
EV / FCF
3.2
Gross margin
100%
EV / Sales
-314.4
ROIC
491%
Div yield
0%
Debt / equity
0.0
52wk Low
$0.55
52wk High
$2.00

APRE stock rating

How APRE scores on quality, value, growth, momentum and financial health
1.1out of 10
Low overallNeutral business, valuation unclearTop 89% of ~5,000 US stocks
QualityPoor0.5/10
GrowthGood6.2/10
MomentumPoor1.8/10
ValueNo scoren/a/10
Financial HealthPoor1.3/10

Growth

Revenue and earnings trend for APRE
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about APRE
Is Aprea Therapeutics a good buy?
No. Aprea Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup.
What is the market capitalization of APRE?
Aprea Therapeutics's market capitalization is $7.74M.
What is the P/E ratio for APRE stock?
Aprea Therapeutics's current P/E ratio is -0.6.
What is the 52-week high for APRE stock?
The 52-week high for Aprea Therapeutics is $2.00. The current close of $0.63 is 68.7% below that high.
What is the 52-week low for APRE stock?
The 52-week low for Aprea Therapeutics is $0.55. The current close of $0.63 is 14.1% above that low.
Does APRE stock pay dividends?
Aprea Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for APRE?
Aprea Therapeutics's Debt / Equity ratio is 0.